"AI diagnostics"

#12994505

16 November 2025

A model holds the AI-supported Portable Tablet PC designed for Endoscopy ''EN-150'' during the press preview of Medica 2025 at the Duesseldorf trade fair center in Duesseldorf, Germany, on November 16, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12994509

16 November 2025

A model holds the AI-supported Portable Tablet PC designed for Endoscopy ''EN-150'' during the press preview of Medica 2025 at the Duesseldorf trade fair center in Duesseldorf, Germany, on November 16, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12570988

21 July 2025

The ''physical examination'' of automobiles through AI and 3D vision technology takes place at the 3rd China International Supply Chain Promotion Expo in Beijing, China, on July 20, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12097657

26 February 2025

A radiologist at Shaoxing Central Hospital performs rapid and accurate diagnoses with the help of an AI image analysis system in Shaoxing, China, on February 25, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12097658

26 February 2025

A radiologist at Shaoxing Central Hospital performs rapid and accurate diagnoses with the help of an AI image analysis system in Shaoxing, China, on February 25, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12097659

26 February 2025

A radiologist at Shaoxing Central Hospital performs rapid and accurate diagnoses with the help of an AI image analysis system in Shaoxing, China, on February 25, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12097660

26 February 2025

A radiologist at Shaoxing Central Hospital performs rapid and accurate diagnoses with the help of an AI image analysis system in Shaoxing, China, on February 25, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950561

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950562

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950563

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950564

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950565

16 January 2025

A desk filled with documents during the testing of the new AILIS machine as part of clinical trials aimed at detecting breast cancer, in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. Using Parametric Dynamic Imaging (PDI) and artificial intelligence, it can distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials are currently conducted in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950566

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950567

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950572

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950573

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.